American Conference Institute plans to hold a two-day “Pharma/Biotech Patent Boot Camp” on June 21-22 in New York.
According to ACI, the conference “has been designed to give new patent attorneys and patent attorneys who are new to the life sciences industries–as well as business executives in pharma and biotech companies–a strong working knowledge of essential IP and regulatory competencies relative to life sciences patents.”
The following talks should be particularly informative:
- The Nature of the Approval Process for Drugs and Biologics: What Every Life Sciences Patent Attorney Should Know
- Pre-Patent Considerations: Product Development, Commercialization and Life Cycle Management
- Freedom to Operate: Review of Analysis and Opinions for Pharma and Biotech Patents
- Bioequivalence and the “Same Active Ingredient” vis-a-vis Patentability
- Exploring Pharmaceutical Patent Extensions: Patent Term Adjustment and Patent Term Restoration
- Perfecting Claims in Life Sciences Patent Applications
- Understanding the Doctrines of Accidental and Inherent Anticipation and their Impact on Life Sciences Patents
- The Safe Harbor: Assessing Protections and Identifying Infringing Activities Relative to Life Science Patents
The co-chairs of the conference are Thomas J. Kowalski (partner, Frommer Lawrence & Haug LLP) and Robert B. Nicholas (partner, McDermott Will & Emery LLP). Additional details and registration information are available at the conference website.
Orange Book Blog is a media partner of this conference.
Orange Book Blog 
Leave a comment